UMPhysicians

Pulmonology

Dr. Jordan M. Dunitz is an expert in the field of Pulmonology. He graduated from Stony Brook University School of Medicine. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Doctor Jordan M. Dunitz, MD is a published doctor as well. He has 33 publications published. The latest was: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. He accepts Medicare.

Publications

---

• Colonoscopic screening shows increased early incidence and progression of adenomas in Cystic fibrosis.
• Diabetes-Related Mortality in Adults with Cystic Fibrosis: Role of Genotype and Gender.
• Early Colon Screening of Adult Patients With Cystic Fibrosis Reveals High Incidence of Adenomatous Colon Polyps.
• Insulin secretion improves in Cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
• Clostridium difficile infection increases mortality risk in Lung transplant recipients.
• Calcineurin inhibitors and Clostridium difficile infection in adult Lung transplant recipients: the effect of cyclosporine versus tacrolimus.
• The rise of Clostridium difficile infection in Lung transplant recipients in the modern era.
• Effect of Endoscopic Sinus Surgery on Pulmonary Status of Adults with Cystic Fibrosis.
• Tracheobronchopathia osteochondroplastica and selective IgA deficiency.
• Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with Cystic fibrosis homozygous for the F508del-CFTR mutation.
• Effect of VX-770 in persons with Cystic fibrosis and the G551D-CFTR mutation.
• Pulmonary vein thrombosis after lung transplantation presenting as stroke.
• High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD.
• Airway anastomotic dehiscence associated with use of sirolimus immediately after Lung transplantation.
• Use of a somatostatin analogue, octreotide acetate, in the management of Acute gastrointestinal graft-versus-host disease.
• Extended valganciclovir prophylaxis to prevent cytomegalovirus after Lung transplantation: a randomized, controlled trial.
• Serum carcinoembryonic antigen as an adjunct to preoperative staging of Lung cancer.
• A pre-post retrospective study of patients with Cystic fibrosis and gastrostomy tubes.
• Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient Cystic fibrosis patients.
• Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.
• Hyperoxia increases active alveolar Na+ resorption in vivo and type II cell Na,K-ATPase in vitro.
• Hyperoxic effects on alveolar sodium resorption and Lung Na-K-ATPase.
• Hepatolithiasis and cholangiocarcinoma in Cystic fibrosis: a case series and review of the literature.
• Comparison of settings used for high-frequency chest-wall compression in Cystic fibrosis.
• HyperAcute rejection in single lung transplantation--case report of successful management by means of plasmapheresis and antithymocyte globulin treatment.
• gamma-Glutamyl transpeptidase is a polarized alveolar epithelial membrane protein.
• RAD in stable lung and Heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis.
• Temporary ECMO support following lung and Heart-lung transplantation.
• Effect of preoperative Pulmonary artery pressure on early survival after lung transplantation for idiopathic Pulmonary fibrosis.
• Post-transplant lymphoproliferative disorders in Lung transplant recipients: 20-yr experience at the University of Minnesota.
• Characteristics of gastroesophageal reflux in adults with Cystic fibrosis.
• Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.

Schools

---

• Stony Brook Univ Health Sciences Center School Of Medicine

• University Minn Hosps

Procedures Preformed

---

• Bronchoscopy
• Thoracentesis
• Ventilation Management

Conditions Treated

---

• Acidosis
• Acute Pharyngitis
• Asthma
• Atelectasis
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Super Doctor

Education

---

• University of Minnesota at Fairview
• Stony Brook University School of Medicine

Hospital

---

• University of Minnesota Medical Center, Fairview

Drug Facts

---

NPI NUMBER		1760413124
NPPES Provider LastName		DUNITZ
NPPES Provider FirstName		JORDAN
NPPES Provider ZIPCode		55455
NPPES Provider State		MN
Specialty Description		Pulmonary Disease
Total Claim Count		2834.0
Distinct Opioid Count		2.0
Opioid Claim Count		27.0
Percent Opioid Claims		0.95

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1760413124
Last Name Of The Provider	DUNITZ
First Name Of The Provider	JORDAN
View All

Similar Doctors

---

	Dr. Abbie L. Begnaud, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan L. Burton, MD This Doctor is OpenDoctor Recommended.
	Dr. Jena N. Wirt, DO
	Dr. Timothy P M. Whelan, MD
	Dr. Elizabeth A. Miller, MD
	Dr. Jeffrey B. Rubins, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Tonia M. Mowbray-Donahue, MD
	Dr. Erin E. Wetherbee, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert R. Kempainen, MD This Doctor is OpenDoctor Recommended.
	Dr. Hyun J. Kim, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher T. Wall, MD This Doctor is OpenDoctor Recommended.
	Dr. David M. Williams, DO
	Dr. Jeffrey R. Johnson, MD
	Sandra J. Lynch
	Sharon Wahl

---

Doctor Directory | TOS | twitter | FB | Angel | blog